| SC 13G/A | 2019-02-11 | Mickle Travis C | KEMPHARM, INC | 2,735,583 | 10.3% | EDGAR |
| SC 13G/A | 2019-01-17 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 4,095,914 | 15.5% | EDGAR |
| SC 13G/A | 2018-11-21 | Flynn James E | KEMPHARM, INC | 822,621 | 3.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Flynn James E | KEMPHARM, INC | 747,309 | 4.8% | EDGAR |
| SC 13G/A | 2018-02-14 | Alyeska Investment Group, L.P. | KEMPHARM, INC | 992,338 | 6.8% | EDGAR |
| SC 13G/A | 2018-02-12 | Mickle Travis C | KEMPHARM, INC | 2,518,916 | 17.2% | EDGAR |
| SC 13G/A | 2018-01-29 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 1,791,631 | 12.2% | EDGAR |
| SC 13G/A | 2017-09-15 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 1,465,743 | 10.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Flynn James E | KEMPHARM, INC | 1,575,342 | 10.0% | EDGAR |
| SC 13G/A | 2017-02-14 | Mickle Travis C | KEMPHARM, INC | 2,353,500 | 16.1% | EDGAR |
| SC 13G | 2017-02-14 | Alyeska Investment Group, L.P. | KEMPHARM, INC | 998,742 | 6.8% | EDGAR |
| SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | KEMPHARM, INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2017-01-10 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 1,462,868 | 9.9% | EDGAR |
| SC 13G/A | 2016-02-16 | Broadfin Capital, LLC | KEMPHARM, INC | 732,338 | 5.0% | EDGAR |
| SC 13G/A | 2016-02-16 | Flynn James E | KEMPHARM, INC | 1,164,087 | 8.0% | EDGAR |
| SC 13G | 2016-02-16 | Mickle Travis C | KEMPHARM, INC | 2,247,283 | 15.5% | EDGAR |
| SC 13G/A | 2016-02-11 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 801,257 | 5.5% | EDGAR |
| SC 13G/A | 2015-12-18 | Flynn James E | KEMPHARM, INC | 1,164,087 | 8.1% | EDGAR |
| SC 13G | 2015-10-28 | Delaware Street Capital Master Fund, L.P. | KEMPHARM, INC | 790,541 | 5.6% | EDGAR |
| SC 13G | 2015-04-29 | Broadfin Capital, LLC | KEMPHARM, INC | 802,400 | 6.0% | EDGAR |